Premarket Mover: X4 Pharmaceuticals Inc (XFOR) Down 3.20%

X4 Pharmaceuticals Inc (XFOR) is lower by Wednesday morning, with the stock falling -3.20% in pre-market trading to 1.21. XFOR's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, X4 Pharmaceuticals Inc ranks higher than 80% of stocks. X4 Pharmaceuticals Inc has risen 19.05% over the past month, closing at $0.99 on August 31. During this period of time, the stock fell as low as $0.89 and as high as $1.23. XFOR has an average analyst recommendation of Strong Buy. The company has an average price target of $6.17.

XFOR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on XFOR!

See Full XFOR Report

X4 Pharmaceuticals Inc has a Long-Term Technical rank of 59. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 41% of the market scoring higher. In the Biotechnology industry which is number 52 by this metric, XFOR ranks better than 52% of stocks.

Important Dates for Investors in XFOR:

-X4 Pharmaceuticals Inc is set to release earnings on 11/3/2022. Over the last 12 months, the company has reported EPS of $-3.36. -We do not have a set dividend date for X4 Pharmaceuticals Inc at this time. Click Here To Get The Full Report on X4 Pharmaceuticals Inc (XFOR)